|
"陳立宗"的相关文件
显示项目 1-25 / 157 (共7页)
1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2020-02-01 |
專題討論（四）
|
邱文泰;楊孔嘉;張權發;蔡佩珍;阮振維;何中良;張定宗;蘇五洲;周楠華;陳柏齡;王憶卿;彭貴春;陳振暐;林世杰;陳立宗;孫孝芳;吳梨華;蔣輯武;王憲威;鄧景浩;張南山;橋本昌征;朱俊憲;劉紋君;孫宏羽;郭余民 |
| 國立成功大學 |
2020-02-01 |
轉譯醫學與臨床試驗特論
|
甘偵蓉;李碧芳;莊偉哲;張明熙;蔡少正;彭貴春;陳立宗;楊延光;呂佩融;沈延盛;謝奇璋;蘇文彬;張南山;謝達斌 |
| 國立成功大學 |
2020-02-01 |
轉譯醫學與臨床試驗特論
|
林宙晴;黃美智;楊延光;林永明;李碧芳;蔡少正;彭貴春;陳立宗;呂佩融;沈延盛;謝達斌 |
| 國立成功大學 |
2020-02-01 |
專題討論（二）
|
邱文泰;楊孔嘉;張權發;蔡佩珍;阮振維;何中良;張定宗;蘇五洲;周楠華;陳柏齡;王憶卿;彭貴春;陳振暐;林世杰;陳立宗;孫孝芳;吳梨華;蔣輯武;王憲威;鄧景浩;張南山;橋本昌征;朱俊憲;劉紋君;孫宏羽;郭余民 |
| 國立成功大學 |
2019-08-01 |
專題討論（一）
|
張孔昭;柯文謙;劉嚴文;許釗凱;顏家瑞;王亮超;湯銘哲;黃一修;陳立宗;呂佩融;洪澤民;林聖翔;沈延盛;謝奇璋;江伯敏;陳芃潔;劉秉彥;蘇文彬;陳玉玲 |
| 國立成功大學 |
2019-08-01 |
專題討論（三）
|
張孔昭;柯文謙;林錫璋;劉嚴文;許釗凱;顏家瑞;王亮超;湯銘哲;黃一修;陳立宗;呂佩融;洪澤民;林聖翔;沈延盛;謝奇璋;江伯敏;陳芃潔;劉秉彥;蘇文彬;陳玉玲 |
| 臺大學術典藏 |
2018-09-10T08:32:52Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, J.-S. and Chao, Y. and Hsieh, R.-K. and Cheng, A.-L. and Chen, P.-M. and Chiou, T.-J. and Chao, T.-Y. and Yeh, K.-H. and Chen, L.-T. and Whang-Peng, J.; 陳仁熙;趙毅;鄭安理;陳博明;邱宗傑;趙祖怡;葉坤輝;陳立宗;彭汪嘉康; CHEN, JEN-SHI;CHAO, YEE;CHENG, ANN-LII;CHEN, PO-MIN;CHIOU, TZEON-JYE;CHAO, TSU-YI;YEH, KUN-HUEI;CHEN, LI-TZONG;WHANG-PENG, JACQUELINE; KUN-HUEI YEH; ANN-LII CHENG; CHEN, JEN-SHI; CHAO, YEE; CHENG, ANN-LII; CHEN, PO-MIN; CHIOU, TZEON-JYE; CHAO, TSU-YI; YEH, KUN-HUEI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE |
| 高雄醫學大學 |
2014 |
RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
|
洪雅靜;吳登強;鄭光宏;陳立宗;洪文俊; Hong, KJ;Wu, DC;Cheng, KH;Chen, LT;Hung, WC |
| 高雄醫學大學 |
2013 |
Management of gastric cancer in Asia: resource-stratified guidelines
|
Shen, L;Han, YS;胡晃鳴;Yeh, KH;楊奕馨;Sano, T;Yang, HK;Zhang, X;Park, SR;Fujii, M;Kang, YK;陳立宗; Shen, L;Han, YS;Hu, HM;Yeh, KH;Yang, YH;Sano, T;Yang, HK;Zhang, X;Park, SR;Fujii, M;Kang, YK;Chen, LT |
| 高雄醫學大學 |
2013 |
Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors
|
薛元碩;Yen, CC;Shih, NY;Chiang, NJ;Li, CF;陳立宗; Hsueh, YS;Yen, CC;Shih, NY;Chiang, NJ;Li, CF;Chen, LT |
| 高雄醫學大學 |
2013 |
ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance.
|
Huang, Hsuan-Ying;Wu, Wen-Ren;Wang, Yu-Hui;Wang, Jun-Wen;Fang, Fu-Min;Tsai, Jen-Wei;Li, Shau-Hsuan;Hung, Hsiao-Chin;Yu, Shih-Chen;Lan, Jui;Shiue, Yow-Ling;Hsing, Chung-His;陳立宗;李健逢; Huang, Hsuan-Ying;Wu, Wen-Ren;Wang, Yu-Hui;Wang, Jun-Wen;Fang, Fu-Min;Tsai, Jen-Wei;Li4, Shau-Hsuan;Hung1, Hsiao-Chin;Yu1, Shih-Chen;Lan1, Jui;Shiue, Yow-Ling;Hsing, Chung-His;Chen*, Li-Tzong;Li, Chien-Feng |
| 高雄醫學大學 |
2013 |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line–A reply
|
郭頌鑫;Weng, Wen-Hui;Yeh, Kun-Huei;陳立宗;鄭安理; Kuo, Sung-Hsin;Weng, Wen-Hui;Yeh, Kun-Huei;Chen, Li-Tzong;Cheng, Ann-Lii |
| 高雄醫學大學 |
2013 |
Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression
|
Sun, Ding-Ping;Lin, Ching-Yih;Tian, Yu-Feng;陳立宗;Lin, Li-Ching;Lee, Sung-Wei;Hsing, Chung-Hsi;Lee, Hao-Hsien;Shiue, Yow-Ling;Huang, Hsuan-Ying;Li, Chien-Feng;Liang, Peir-In; Sun, Ding-Ping;Lin, Ching-Yih;Tian, Yu-Feng;Chen, Li-Tzong;Lin, Li-Ching;Lee, Sung-Wei;Hsing, Chung-Hsi;Lee, Hao-Hsien;Shiue, Yow-Ling;Huang, Hsuan-Ying;Li, Chien-Feng;Liang, Peir-In |
| 高雄醫學大學 |
2013 |
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
|
Liang, Peir-In;Wang, Yu-Hui;Wu, Ting-Feng;Wu, Wen-Ren;Liao, Alex C;Shen, Kun-Hung;Hsing, Chung-Hsi;Shiue, Yow-Ling;Huang, Hsuan-Ying;Hsu, Han-Ping;陳立宗;Lin, Ching-Yih;Tai, Chein;Wu, Jui-Yu;李健逢; Liang, Peir-In;Wang, Yu-Hui;Wu, Ting-Feng;Wu, Wen-Ren;Liao, Alex C;Shen, Kun-Hung;Hsing, Chung-Hsi;Shiue, Yow-Ling;Huang, Hsuan-Ying;Hsu, Han-Ping;Chen, Li-Tzon;Lin, Ching-Yih;Tai, Chein;Wu, Jui-Yu;Li , Chien-Feng |
| 高雄醫學大學 |
2013 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer.
|
Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;陳立宗; Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;Chen, LT. |
| 高雄醫學大學 |
2013 |
Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma
|
Kao, YC;Lee, SW;Lin, LC;陳立宗;Hsing, CH;Hsu, HP;Huang, HY;Shiue, YL;Chen, TJ;李健逢; Kao, YC;Lee, SW;Lin, LC;Chen, LT;Hsing, CH;Hsu, HP;Huang, HY;Shiue, YL;Chen, TJ;Li, CF |
| 高雄醫學大學 |
2013 |
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
|
連培因;Wang, Yu-Hui;Wu, Ting-Feng;Wu, Wen-Ren;Liao, Alex C;Shen, Kun-Hung;Hsing, Chung-Hsi;Shiue, Yow-Ling;Huang, Hsuan-Ying;Hsu, Han-Ping;陳立宗;Lin, Ching-Yih;Tai, Chein;Wu, Jui-Yu;李健逢; Liang, Peir-In;Wang, Yu-Hui;Wu, Ting-Feng;Wu, Wen-Ren;Liao, Alex C;Shen, Kun-Hung;Hsing, Chung-Hsi;Shiue, Yow-Ling;Huang, Hsuan-Ying;Hsu, Han-Ping;Chen, Li-Tzon;Lin, Ching-Yih;Tai, Chein;Wu, Jui-Yu;Li , Chien-Feng |
| 高雄醫學大學 |
2013 |
Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
|
Sun, DP;Lin, CY;Tian, YF;陳立宗;Lin, LC;Lee, SW;Hsing, CH;Lee, HH;Shiue, YL;Huang, HY;李健逢;連培因; Sun, DP;Lin, CY;Tian, YF;Chen, LT;Lin, LC;Lee, SW;Hsing, CH;Lee, HH;Shiue, YL;Huang, HY;Li, CF;Liang, PI |
| 高雄醫學大學 |
2012 |
輔助性甲型干擾素在完全切除肝細胞癌之觀察組對隨機分組第三期臨床試驗之長期追蹤結果
|
陳立宗;陳敏夫;李隆安;李伯皇;鄭隆賓;林灯寅;吳誠中;莫錦堂;陳肇隆;李威震;周嘉陽;陳耀森;雷永燿;簫金福;彭汪嘉康;陳培哲 ; Li-Tzong Chen;Miin-Fu Chen;Lung-An Li;Po-Huang Lee;Long-Bin Jeng;Deng-Yn Lin;Cheng-Chung Wu;King-Tong Mok;Chao-Long Chen;Wei-Chen Lee;Gar-Yang Chau;Yaw-Sen Chen;Wing-Yui Lui;Chin-Fu Hsiao;Jacqueline Whang-Peng;Pei-Jer Chen |
| 高雄醫學大學 |
2012 |
Hepatitis B Reactivation in Advanced Hepatocellular Carcinoma Treated with Everolimus
|
戴嘉言;夏和雄;陳迥瑜;蕭金福;林毅志;蘇五洲;張俊彥;Winkler, Robert E;彭汪嘉康;林炳文;黃金鼎;余明隆;莊萬龍;陳立宗 |
| 高雄醫學大學 |
2012 |
透析前後罹患上泌尿道癌症病人的特性分析-以母群體為基礎的研究
|
林明彥;郭美娟;陳立宗;吳文正;陳鴻均;黃尚志 |
| 高雄醫學大學 |
2011 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.
|
盧勝男;趙毅;王蒼恩;陳信成;彭康嘉康;陳培哲;陳立宗 ; Yang TS;Lu SN;Chao Y;Sheen IS;Lin CC;Wang TE;Chen SC;Wang JH;Liao LY;Thomson JA;Wang-Peng J;Chen PJ;Chen LT. |
| 高雄醫學大學 |
2011 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
|
趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. |
| 高雄醫學大學 |
2011 |
Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036.
|
陳立宗; Yang YN;Chou KM;Pan WY;Chen YW;Tsou TC;Yeh SC;Cheung CH;Chen LT;Chang JY. |
| 高雄醫學大學 |
2011 |
2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
|
陳立宗; Chuang HY;Chang JY;Lai MJ;Kuo CC;Lee HY;Hsieh HP;Chen YJ;Chen LT;Pan WY;Liou JP. |
显示项目 1-25 / 157 (共7页)
1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
|
